Stratasys Creates 3...
Health Care: Drugs
Affymax Inc. (AFFY: NASDAQ)
$1.40 -0.05 | -3.45%
05/22/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 94.37M | 47.72M | 112.52M | 114.90M |
| Cost of Sales | 42.90M | 0.00 | 0.00 | -2.16M |
| Gross Operating Profit | 51.48M | 47.72M | 112.52M | 117.06M |
| Selling, General, and Administrative Expenses | 89.71M | 32.82M | 33.33M | 36.72M |
| Research & Development | 51.74M | 76.31M | 93.64M | 157.12M |
| Operating Income before D & A (EBITDA) | -89.98M | -61.41M | -14.45M | -76.78M |
| Depreciation & Amortization | 2.06M | 2.24M | 2.86M | 2.16M |
| Interest Income | 77.00K | 169.00K | 275.00K | 934.00K |
| Other Income - Net | -34.00K | 15.00K | 239.00K | 171.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -92.00M | -63.46M | -16.80M | -77.84M |
| Interest Expense | 1.44M | 144.00K | 140.00K | 105.00K |
| Pre-Tax Income | -93.44M | -63.60M | -16.94M | -77.94M |
| Income Taxes | -26.00K | 1.00K | 1.00K | -1.41M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -93.41M | -61.37M | -14.08M | -76.53M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -93.41M | -61.37M | -14.08M | -76.53M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -93.41M | -61.37M | -14.08M | -76.53M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-93.41M | -61.37M | -14.08M | -76.53M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -93.41M | -61.37M | -14.08M | -76.53M |
| Basic EPS from Continuing Ops. | -2.57 | -1.84 | -0.57 | -4.06 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -2.57 | -1.84 | -0.57 | -4.06 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -2.57 | -1.84 | -0.57 | -4.06 |
| Basic Normalized Net Income/Share | -2.57 | -1.84 | -0.57 | -4.06 |
| EPS fr Continuing Ops. | -2.57 | -1.84 | -0.57 | -4.06 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -2.57 | -1.84 | -0.57 | -4.06 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -2.57 | -1.84 | -0.57 | -4.06 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-2.57 | -1.84 | -0.57 | -4.06 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with AFFY
- Portfolio NameUser Type
- ContributorMost-Active Stocks for the ...
- ContributorMost-Active Stocks for the ...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
Latest AFFY Headlines from TheStreet
- 4 Hot Stocks to Trade (or Not) 05.09.13 | 01:05 pm
- 2 Drug Stocks Under $10 To Pick As Favorites 03.25.13 | 02:03 pm
- 5 Big Stocks to Trade (or Not) 03.19.13 | 02:03 pm
- 4 Biotech Stocks Under $5 to Watch 03.15.13 | 07:03 am
- Biotech Stock Mailbag: Delcath, Navidea, Affymax, Ziopharm 03.15.13 | 06:03 am
- 5 Stocks Ready to Break Out 03.08.13 | 02:03 pm
- 5 Stocks Poised for Breakouts 03.01.13 | 02:03 pm
- 3 Stocks Pushing The Drugs Industry Lower 02.25.13 | 12:02 pm
- Affymax Is Done. RIP. 02.25.13 | 10:02 am
- Affymax, Takeda Recall Anemia Drug 02.24.13 | 05:02 pm
Press Releases for AFFY
- Harwood Feffer LLP Announces Investigation Of Affymax, Inc. - PR Newswire 04.03.13 | 04:04 pm
- Lifshitz Law Firm Announces Class Action Lawsuits Against Affymax, Inc., Impax Laboratories Inc., And Tangoe, Inc. - PR Newswire 03.18.13 | 07:03 pm
- Affymax Announces Reduction In Force To Align Resources Around Ongoing Product Investigation - Business Wire 03.18.13 | 05:03 pm
- Lawyers Seek To Restore Investors' Losses And Confidence In Affymax, Announces Deans & Lyons Law Firm LLP - Business Wire 03.11.13 | 02:03 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Affymax, Inc. To Contact The Firm - PR Newswire 03.01.13 | 09:03 pm
- A Securities Fraud Class Action Lawsuit Has Been Filed Against Affymax, Inc., Shareholders Are Encouraged To Contact Holzer Holzer & Fistel, LLC - Business Wire 02.28.13 | 12:02 pm
- Finkelstein Thompson LLP Announces Investigation Of Affymax, Inc. - Business Wire 02.27.13 | 05:02 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Affymax, Inc. - PR Newswire 02.25.13 | 10:02 am
- Affymax Announces Teleconference And Webcast - Business Wire 02.25.13 | 08:02 am
- Affymax And Takeda Announce A Nationwide Voluntary Recall Of All Lots Of OMONTYS® (peginesatide) Injection - Business Wire 02.23.13 | 07:02 pm
Partner Headlines for AFFY
- Affymax Earnings:Here’s Why the Stock is Falling Now - Wall St. Cheat Sheet 04.02.13 | 12:04 pm
- Will Affymax’s Loss Annoy These Top Institutional Shareholders? - Wall St. Cheat Sheet 04.02.13 | 12:04 pm
- Pre-Market Most Active for Mar 12, 2013 : ZNGA, GLUU, BBRY, SNE, MRK, BCS, MT, GOV, BAC, ARMH, AAPL, AFFY - NASDAQ 03.12.13 | 12:03 pm
- FDA Recalls Affymax Omontys - Benzinga 03.08.13 | 07:03 pm
- Pre-Market Most Active for Mar 8, 2013 : BAC, BCS, QQQ, C, NOK, V, GDI, AFFY, SKUL, HOTT, FB, BBRY - NASDAQ 03.08.13 | 01:03 pm
- Pre-Market Most Active for Feb 26, 2013 : SAN, BBVA, TEF, BAC, FTE, SNY, ZNGA, SIRI, AFFY, VVUS, BBRY, FB - NASDAQ 02.26.13 | 01:02 pm
- After Hours Most Active for Feb 25, 2013 : QQQ, BAC, SIRI, MT, XOM, NLY, T, FB, AA, AFFY, INTC, MSFT - NASDAQ 02.25.13 | 09:02 pm
- Stocks Stay Down, Near Day's Lows, But Amgen Hits High - Investor's Business Daily 02.25.13 | 03:02 pm
- Pre-Market Most Active for Feb 25, 2013 : AFFY, ZNGA, BAC, VOD, BBRY, ELN, ING, NOK, BCS, BP, FB, SIRI - NASDAQ 02.25.13 | 01:02 pm
- Beat and Raise Quarter for Amgen - Analyst Blog - Zacks 10.24.12 | 09:10 am
